Lung cancer is the third most common type of cancers in the United States, according to the Cancers for Disease Control and Prevention. A new study has found a new way for…
Tag: Lung Cancer
Moffitt Researchers Find New Target for CAR T Cells in Solid Tumors
The researchers from Moffitt Cancer Center in Tampa, Florida have published results identifying the potential target for Chimeric Antigen Receptor (CAR) T-cell therapies in solid tumors. The findings have been published in…
Researchers Show Link between Air Pollution and Lung Cancer Susceptibility
According to the recent study published in journal eLife, scientists have discovered the mechanism that explains how small air pollution particles may be responsible for occurrence of lung cancer. These findings could…
All You Need to Know About Pediatric Non-Small Cell Lung Cancer
Primary lung cancer is extremely rare in children. Pediatric non-small cell lung cancer (NSCLC) is the term for occurrence of NSCLC in children and adolescents. NSCLC that develops in young people is…
What is Lung Biopsy?
Lung biopsy is a form of medical treatment and there can be a number of reasons for doctors recommending it. Then, there are several types of biopsy and one selects according to…
Personalized Blood Test to Help Selection of Lung Cancer Treatment
University of Cambridge has led a study that showed that a personalized blood test performed after lung cancer treatment could help in detection of patients who are at high risk of return…
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small cell lung cancer. This approval applies to the use…
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the first immune checkpoint inhibitor to get approval for resectable NSCLC….